Peraso Inc. (NASDAQ: PRSO) Rides Military AI Boom as Defense Spending Surges - More Stocks Inside

Peraso Inc. (NASDAQ: PRSO) Rides Military AI Boom as Defense Spending Surges - More Stocks Inside

As global defense spending surges, investors are turning their attention to AI-driven military technologies, fueling demand for secure, high-speed communication systems. Peraso Inc. (NASDAQ: PRSO) is emerging as a key player in this evolving sector, leveraging its millimeter wave (mmWave) technology to provide low-latency, interference-free communications, critical for military drone surveillance, real-time battlefield intelligence, and defense networking. With defense agencies prioritizing next-gen connectivity solutions, PRSO stands poised for potential military contracts and strategic partnerships. Also AI-powered biotech stocks gaining attention, mentioned inside this article.

Financial & Market Indicators:

* Defense Spending Growth: The U.S. defense budget exceeded $850 billion in 2024, with AI-driven military projects receiving increased funding for advanced communication and security solutions-a sector where Peraso's mmWave technology thrives.
* Comparison to GSI Technology (NASDAQ: GSIT): GSIT, which specializes in AI-powered military computing, saw a 43% surge after securing a U.S. Army contract, underscoring the market potential for similar small-cap stocks like PRSO.
* Potential for Military Contracts: PRSO's mmWave solutions align with government and defense agency needs, making it a top contender for future defense technology contracts.

Why PRSO is a Smart Play for Defense Investors:

* High-Security Communication: PRSO's mmWave technology is resistant to jamming and interference, making it ideal for military drone operations and secure battlefield intelligence.
* Growing Industry Momentum: As military AI adoption accelerates, investors are seeking defense-tech crossover stocks, positioning PRSO as a rare, publicly traded player in this space.
* Small-Cap Growth Potential: Unlike large-cap defense stocks, PRSO remains undervalued, giving early investors a chance to capitalize on its emerging role in AI-powered defense technology.

Additional AI Medical Market Movers to Watch:

* Kairos Pharma (NYSE: KAPA) is pioneering immune-suppression resistant cancer therapeutics, with a pipeline targeting prostate cancer, lung cancer, breast cancer, and glioblastoma.
* Quantum BioPharma (NASDAQ: QNTM) confirmed its supplement unbuzzd Trademark accelerates alcohol metabolism, reducing BAC by over 40% in 30 minutes, improving alertness and cognitive function.
* Evaxion Biotech (NASDAQ: EVAX) closed a $10.8 million public offering to advance its AI-powered cancer immunotherapy candidates, backed by Merck's MSD Global Health Innovation Fund.
* Invivyd (NASDAQ: IVVD) reported positive Phase 1/2 clinical data for VYD2311, a long-acting alternative to COVID-19 vaccines, with 17x greater neutralization potency than pemivibart.

As defense budgets rise and AI-driven military tech advances, PRSO's mmWave solutions present a strong investment opportunity in the defense-tech sector. Meanwhile, AI-powered biotech stocks like KAPA, QNTM, IVVD and EVAX, are gaining traction in next-gen immunotherapy and antibody treatments, highlighting AI's impact on healthcare. With potential military contracts and industry momentum, PRSO is poised for breakout growth, making it a top watchlist stock alongside KAPA, QNTM, IVVD, EVAX and GSIT.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=peraso-inc-nasdaq-prso-rides-military-ai-boom-as-defense-spending-surges-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.